MedPath

Multimodal treatment of HCC, Bile duct cancer and metastatic liver cancer: a multi-institutional retrospective study

Not Applicable
Conditions
Hepatocellular carcinoma, intrahepatic cholangiocarcinoma, neuroendocrine or colorectal liver metastases
Registration Number
JPRN-UMIN000033823
Lead Sponsor
Yokohama City University Hospital, Department of Gastoenterological Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1829
Inclusion Criteria

Not provided

Exclusion Criteria

No pathologic confirmation of tumor Age <18 years

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
long-term outcomes of patients from multimodal treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath